4//SEC Filing
Exploration Capital, LLC 4
Accession 0001213900-24-035431
CIK 0000819050other
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 5:10 PM ET
Size
9.9 KB
Accession
0001213900-24-035431
Insider Transaction Report
Form 4
Exploration Capital, LLC
10% Owner
Transactions
- Purchase
Common Stock
2024-04-22$0.90/sh+16,908$15,217→ 1,060,464 total - Purchase
Common Stock
2024-04-23$0.91/sh+343$312→ 1,060,807 total - Purchase
Common Stock
2024-04-19$0.91/sh+4,277$3,892→ 1,043,556 total
Holdings
- 47,000
Common Stock
Footnotes (3)
- [F1]Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
- [F2]Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.
- [F3]These shares are directly owned by Stephen L. Gustin.
Documents
Issuer
Fresh Tracks Therapeutics, Inc.
CIK 0000819050
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0002003514
Filing Metadata
- Form type
- 4
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 5:10 PM ET
- Size
- 9.9 KB